These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

775 related articles for article (PubMed ID: 9220352)

  • 1. Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies.
    Docherty JC; Gunter HE; Kuzio B; Shoemaker L; Yang L; Deslauriers R
    J Mol Cell Cardiol; 1997 Jun; 29(6):1665-73. PubMed ID: 9220352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide.
    Ferdinandy P; Szilvássy Z; Droy-Lefaix MT; Tarrade T; Koltai M
    Cardiovasc Res; 1995 Nov; 30(5):781-7. PubMed ID: 8595627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes and ATP-sensitive potassium channel openers and blockers in isolated ischemic/reperfused hearts.
    Tosaki A; Engelman DT; Engelman RM; Das DK
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1115-23. PubMed ID: 8531071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?
    Tosaki A; Szerdahelyi P; Engelman RM; Das DK
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1355-62. PubMed ID: 8263798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.
    Grover GJ; D'Alonzo AJ; Garlid KD; Bajgar R; Lodge NJ; Sleph PG; Darbenzio RB; Hess TA; Smith MA; Paucek P; Atwal KS
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1184-92. PubMed ID: 11356945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
    Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
    Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardioprotective effect of cromakalim, a K+ channel opener, on isolated globally ischemic and reperfused rat hearts].
    Taki H; Masuda Y; Yoshizumi M; Kitagawa T; Katoh I
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Mar; 41(3):438-44. PubMed ID: 8478573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury--Evidence for a role of K ATP channels.
    Johansen D; Ytrehus K; Baxter GF
    Basic Res Cardiol; 2006 Jan; 101(1):53-60. PubMed ID: 16328106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Block of cardiac ATP-sensitive K(+) channels reduces hydroxyl radicals in the rat myocardium.
    Obata T; Yamanaka Y
    Arch Biochem Biophys; 2000 Jun; 378(2):195-200. PubMed ID: 10860536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KATP channel modulators and myocardial damages induced by ischemia-reperfusion: membrane lipids injury and arrhythmias.
    Picard S; Rouet R; Duval D; Chesnay F; Gérard JL
    J Mol Cell Cardiol; 1998 Dec; 30(12):2613-21. PubMed ID: 9990533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts.
    Tosaki A; Hellegouarch A
    J Am Coll Cardiol; 1994 Feb; 23(2):487-96. PubMed ID: 8294705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial uncoupling, with low concentration FCCP, induces ROS-dependent cardioprotection independent of KATP channel activation.
    Brennan JP; Southworth R; Medina RA; Davidson SM; Duchen MR; Shattock MJ
    Cardiovasc Res; 2006 Nov; 72(2):313-21. PubMed ID: 16950237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K(ATP)-channel activation: effects on myocardial recovery from ischaemia and role in the cardioprotective response to adenosine A1-receptor stimulation.
    Ford WR; Lopaschuk GD; Schulz R; Clanachan AS
    Br J Pharmacol; 1998 Jun; 124(4):639-46. PubMed ID: 9690854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of potassium channel blockade on the anti-ischemic actions of mechanistically diverse agents.
    Sargent CA; Smith MA; Dzwonczyk S; Sleph PG; Grover GJ
    J Pharmacol Exp Ther; 1991 Oct; 259(1):97-103. PubMed ID: 1920138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects against hydrogen peroxide-induced toxicity by activators of the ATP-sensitive potassium channel in isolated rat hearts.
    Gan XT; Cook MA; Moffat MP; Karmazyn M
    J Mol Cell Cardiol; 1998 Jan; 30(1):33-41. PubMed ID: 9500862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of K(atp)channel activation on myocardial cationic and energetic status during ischemia and reperfusion: role in cardioprotection.
    Fukuda H; Luo CS; Gu X; Guo L; Digerness SB; Li J; Pike MM
    J Mol Cell Cardiol; 2001 Mar; 33(3):545-60. PubMed ID: 11181022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotective effects of a novel calcium antagonist related to the structure of cromakalim.
    Grover GJ; Sleph PG; Dzwonczyk S; McCullough JR
    J Pharmacol Exp Ther; 1993 Oct; 267(1):102-7. PubMed ID: 8229736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemic preconditioning: bioenergetic and metabolic changes and the role of endogenous adenosine.
    Headrick JP
    J Mol Cell Cardiol; 1996 Jun; 28(6):1227-40. PubMed ID: 8782064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448.
    Grover GJ; McCullough JR; D'Alonzo AJ; Sargent CA; Atwal KS
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):40-50. PubMed ID: 7723352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repetitive acidosis protects the ischemic heart: implications for mechanisms in preconditioned hearts.
    Lundmark JA; Trueblood N; Wang LF; Ramasamy R; Schaefer S
    J Mol Cell Cardiol; 1999 Apr; 31(4):907-17. PubMed ID: 10329217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.